1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow TBI-223: new trials by email Literature Review of TBI-223 trials Research Report on TBI-223
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis Isoniazid, Rifampicin, Pyrazinamide - Pulmonary Tuberculosis | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 315 | 2025-03-11 | 2026-10-19 |
National Institute of Allergy and Infectious Diseases (NIAID) (1)
Botswana (1) · Brazil (1) · Haiti (1) · India (1) · Kenya (1) · Malawi (1) · Mexico (1) · Peru (1) · Philippines (1) · South Africa (1) · Thailand (1) · Uganda (1) · Vietnam (1) · Zimbabwe (1)
Kelly Dooley, MD, PhD (1) · Radojka Savic, PharmD, PhD (1)